改良双手吻合法在腹腔镜下根治性前列腺切除术膀胱尿道吻合中的应用效果  

Application effect of improved bimanual anastomosis in bladder and urethra anastomosis in laparoscopic radical prostatectomy

作　　者：唐彬洋 袁顺辉[1] 韦海荣[1] 席亮 郝左奇 Tang Binyang;Yuan Shunhui;Wei Hairong;Xi Liang;Hao Zuoqi(Department of Urology,the Second Affiliated Hospital of Kunming Medical University,Kunming,Yunnan 650101,China)

机构地区：[1]昆明医科大学第二附属医院泌尿外科,云南昆明650101

出　　处：《中国内镜杂志》2023年第11期80-85,共6页China Journal of Endoscopy

基　　金：云南省科技厅科技计划项目(No:202101AY070001-144)。

摘　　要：目的探讨改良双手吻合法在腹腔镜下根治性前列腺切除术膀胱尿道吻合中的应用效果。方法回顾性分析2019年9月-2022年9月该科186例应用改良双手吻合法进行手术治疗的前列腺癌患者的临床资料。结果186例患者均成功采用改良双手吻合法,在腹腔镜下根治性前列腺切除术中对膀胱尿道实施吻合处理,术后均未出现严重并发症。膀胱与后尿道吻合手术时间(17±5)min,术后住院时间(7±2)d。目前,186例患者尿控情况恢复均较佳,在病情康复过程中,均未出现吻合口瘘和狭窄等并发症。结论在腹腔镜下根治性前列腺切除术膀胱尿道吻合中,应用改良双后吻合法,用于治疗前列腺癌,效果显著,对机体的创伤相对较小,且安全性高,有利于患者术后快速恢复,值得临床推广应用。Objective To investigate the effect of bladder-urethral anastomosis in laparoscopic radical prostatectomy with improved bimanual anastomosis.Methods From September 2019 to September 2022,the diagnosis and treatment data of 186 prostate cancer patients treated by improved bimanual anastomosis were retrospectively studied.Results 186 cases were successfully treated with bladder and urethra anastomosis after laparoscopic radical prostatectomy by modified bimanual anastomosis,and no major complications were found after operation.The operation time of bladder and posterior urethra anastomosis was(17±5)min and the postoperative hospital stay was(7±2)d.At present,186 patients had a good recovery of urinary control,and there was no anastomotic leakage or stenosis in the process of recovery.Conclusion The improved bimanual anastomosis is effective in the treatment of prostate cancer in laparoscopic radical prostatectomy,with relatively less trauma and high safety,which is beneficial to the rapid recovery of patients’health after operation.It can be developed into a recommended treatment for laparoscopic urethral anastomosis in clinical laparoscopic prostate cancer surgery.

关 键 词：腹腔镜检查 前列腺癌 根治性前列腺切除术 外科吻合术 

分 类 号：R737.25[医药卫生—肿瘤]